Clinical Trial: Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to assess the safety and efficacy of pirfenidone capsules to treat grade 2 or above radiation-induced lung injury patients.

Detailed Summary:
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.

Current Primary Outcome: Changes in radiation-induced lung injury classification [ Time Frame: 36 Weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Beijing Continent Pharmaceutical Co, Ltd.

Dates:
Date Received: November 18, 2014
Date Started: January 2015
Date Completion:
Last Updated: November 19, 2014
Last Verified: November 2014